People
Bruce Thompson
Bruce Thompson is published by Kineticos Life Sciences as Strategic Advisor. Bruce is the CEO of Kincell Bio, bringing over 28 years of experience to his position. Prior to his role with Kincell Bio, LLC., Bruce was Vice President and Technical Lead for the Cell Therapy Franchise at Resilience, Inc., where he helped to build the development and GMP manufacturing capabilities and served as a technical advisor both internally and externally. He has over 18 years of CMC strategy, product development and cell therapy manufacturing experience. In his first startup role, he was Vice President of Process Sciences at Lyell Immunopharma, where he was responsible for Process and Analytical Development, as well as tech transfer of processes and methods to a newly built state-of-the-art cGMP facility. Prior to Lyell, Bruce served as the Sr. Director of the Therapeutic Products Program at Fred Hutchinson Cancer Research Center (FHCRC), where he led GMP manufacturing of cell and gene therapy products. He was responsible for supporting >15 active clinical programs and contributed to the filing of 6 INDs for various cell therapy programs. As part of his early career development, Bruce spent nearly 10 years at Pfizer in the Pharmaceutical Sciences division where he gained expertise in analytical and process development. Bruce received his B.A. in Biology, an M.S. in Biochemistry from The Ohio State University and Ph.D. in Microbiology and Immunology from the University of Louisville. Outside-company appointments in this source summarize published experience; no additional current external employer, directorship or personal investment check is inferred.
Roles
Strategic Advisor